Founded in 1986, Tullis Health Investors is a Palm Beach, Florida venture capital firm. They invest in the medical devices, healthcare services, healthcare infrastructure and distribution, healthcare information technology, biotechnology and pharmaceuticals sectors. Tullis Health Investors manage five funds focused on investments in North America and Asia.
Tullis Health Investors has made investments in Exagen, Estech, CareSync, OrthoSensor, Surefire Medical, BioBehavioral Diagnostics, Synageva Biopharma, Aldagen, Atritech, Impulse Monitoring and TransMolecular.
Tullis Health Investors exited their investments in Exagen, CareSync, Synageva BioPharma, Coherex Medical, Estech, Aldagen, Atritech, Myocor, Adiana, BioRexis and TransMolecular.
AtriCure, Inc. is a medical device company that provides innovative solutions for the treatment of atrial fibrillation (Afib) and related conditions.
A biopharmaceutical company that develops and commercializes protein therapeutics for the treatment of rare diseases
BioBehavioral Diagnostics was founded in 2004 and manufactures technologies for the diagnosis and management of neurological and psychiatric conditions.
Barbara Bierer, MD
Vice President, Administration
David Leffel, MD
Founding General Partner
Managing General Partner
Investor Relations Administrator
Chief Financial Officer
Tina Nova, PhD
Advisory Board Member